1. Stocks
  2. Torrent Pharmaceuticals Ltd.
  3. Swot
swot-logo

Torrent Pharmaceuticals Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Torrent Pharmaceuticals Ltd. has 22 Strengths, 6 Weaknesses, 8 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Expensive Performers (DVM)

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Top Gainers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Broker price or reco upgrades in last month

Brokers upgraded recommendation or target price in the past three months

Mutual Funds Increased Shareholding in Past Month

Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month

FII / FPI or Institutions increasing their shareholding

Broker price or reco upgrades in last month

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Companies with high market cap, lower public shareholding

MFs decreased their shareholding last quarter

High Piotroski Score - Companies with strong financials

Expensive Performers (DVM)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks